ID: ALA4867711

Max Phase: Preclinical

Molecular Formula: C14H14N4O3

Molecular Weight: 286.29

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  Cc1ncc([N+](=O)[O-])n1CCOCc1ccc(C#N)cc1

Standard InChI:  InChI=1S/C14H14N4O3/c1-11-16-9-14(18(19)20)17(11)6-7-21-10-13-4-2-12(8-15)3-5-13/h2-5,9H,6-7,10H2,1H3

Standard InChI Key:  RITXIVOTQFRVIG-UHFFFAOYSA-N

Associated Targets(non-human)

Pancreatic alpha-amylase 211 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 286.29Molecular Weight (Monoisotopic): 286.1066AlogP: 2.19#Rotatable Bonds: 6
Polar Surface Area: 93.98Molecular Species: NEUTRALHBA: 6HBD: 0
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 3.03CX LogP: 1.76CX LogD: 1.76
Aromatic Rings: 2Heavy Atoms: 21QED Weighted: 0.46Np Likeness Score: -2.00

References

1. Patel OPS, Jesumoroti OJ, Legoabe LJ, Beteck RM..  (2021)  Metronidazole-conjugates: A comprehensive review of recent developments towards synthesis and medicinal perspective.,  210  [PMID:33234343] [10.1016/j.ejmech.2020.112994]

Source